Latest Issue

Volume 22 Issue 4

Paper of the Month

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

Lindsley RC, Mar BG, Mazzola E et al.
Dana–Farber Cancer Institute, Boston, MA, USA.
Blood 2014 Dec 30; Epub ahead of print.
Acute myeloid leukemia (AML) can be classified, on the basis of clinical ontogeny, as secondary AML (s-AML) that occurs upon transformation of a preceding myelodysplastic syndrome (MDS) or myeloproliferative neoplasm, therapy-related AML (t-AML) that develops as a complication of leukemogenic treatments, or de novo AML that arises in the absence of demonstrable treatment exposure or preceding disease.
» Read an expert review of this paper

Webcast

Our most popular articles

Latest news

  • Home
  • Home
  • Home
  • Home
  • Home
  • Home

READER POLL

L&L poll 2
What do you consider to be the most exciting advances in therapeutics research in myeloid leukemia at present?






Powered by NetPolls

READER SURVEY

SUBMIT AN ARTICLE

OTHER REMEDICA JOURNALS

COMPASS PUBMED SEARCH

Enter your search terms below to search pubmed for articles